Regulus Therapeutics Inc (NASDAQ: RGLS) Is Getting Increasingly Hard To Ignore
Currently, there are 66.28M common shares owned by the public and among those 57.33M shares have been available to trade. The company’s stock has a 5-day price change of -0.73% and 466.67% over the past three months. RGLS shares are trading 223.81% year to date (YTD), with the 12-month market performance up to 416.46% higher. […]